Impact of prior paclitaxel-based chemotherapy on the outcome of salvage high-dose chemotherapy (HDCT) for relapsed germ-cell tumors (GCT): EBMT Solid Tumors Working Party (STWP)-sponsored retrospective study

被引：0

作者：

Necchi, A. ^{[1
]}

Miceli, R. ^{[2
]}

Bregni, M. ^{[3
]}

Berger, L. A. ^{[4
]}

Oechsle, K. ^{[4
]}

Schumacher, K. ^{[5
]}

Apperley, J. ^{[6
]}

Bourhis, J. H. ^{[7
]}

Laszlo, D. ^{[8
]}

Flechon, A. ^{[9
]}

Arpaci, F. ^{[10
]}

Secondino, S. ^{[11
]}

Dreger, P. ^{[12
]}

Crysandt, M. ^{[13
]}

Plueger, K. H. ^{[14
]}

Worel, N. ^{[15
]}

Krueger, W. ^{[16
]}

Ringhoffer, M. ^{[17
]}

Unal, A. ^{[18
]}

Nagler, A. ^{[19
]}

Michieli, M. ^{[20
]}

Campos, A. ^{[21
]}

Wahlin, A. ^{[22
]}

Sucak, G. ^{[23
]}

Schots, R. ^{[24
]}

Donnini, I. ^{[25
]}

Raggi, D. ^{[1
]}

Giannatempo, P. ^{[1
]}

Ifrah, N. ^{[26
]}

Badoglio, M. ^{[27
]}

Martino, M. ^{[28
]}

Pedrazzoli, P. ^{[11
]}

Lanza, F. ^{[29
]}

机构：

[1] Fdn IRCCS Ist Nazl Tumori, Med Oncol, Milan, Italy

[2] Fdn IRCCS Ist Nazl Tumori, Clin Epidemiol & Trials Org Unit, Milan, Italy

[3] Azienda Osped Busto Arsizio, Med Oncol, Busto Arsizio, Italy

[4] KMT Univ Klinikum Hamburg Eppendorf, Med Oncol, Hamburg, Germany

[5] UKGM Marburg Klin Hematol & Oncol, Med Oncol, Marburg, Germany

[6] Univ London Imperial Coll Sci Technol & Med, Hematol, London, England

[7] Gustave Roussy Inst Cancerol, Hematol BMT, Villejuif, France

[8] European Inst Oncol, Hematol BMT, Milan, Italy

[9] Ctr Leon Berard, Hematol, F-69373 Lyon, France

[10] Gulhane Mil Med Acad, GATA BMT Ctr, Ankara, Turkey

[11] Fdn IRCCS Policlin San Matteo, Med Oncol, Pavia, Italy

[12] Univ Klinikum Heidelberg, Hematol, Heidelberg, Germany

[13] Univ Hosp Aachen, Dept Oncol Hematol & SCT, Med Klin 4, Aachen, Germany

[14] EV Diakonie Krankenhaus Gemeinnitzige GmbH, Hematol, Bremen, Germany

[15] Med Univ Vienna, BMT Unit, Vienna, Austria

[16] Univ Med, Klin Innere Med Hamat Onkol C, Greifswal, Germany

[17] Klinikum Karlsruhe gGmbH, Med Klin Haematol 3, Onkol, Karlsruhe, Germany

[18] Kapadokya Cappadocia BMT Ctr, Erciyes Med Sch, Dept Hematol Oncol, Kayseri, Turkey

[19] Chaim Sheba Med Ctr, BMT Unit, IL-52621 Tel Hashomer, Israel

[20] IRCCS Aviano, CRO, Hematol, Aviano, Italy

[21] Inst Portugues Oncol Porto, BMT Unit, Oporto, Portugal

[22] Umea Univ Hosp, Hematol, Umea, Sweden

[23] Gazi Univ Med, Dept Hematol & Stem Cell Transplantat, Ankara, Turkey

[24] Univ Ziekenhuis Brussel, Div Clin Hematol, Brussels, Belgium

[25] Univ Hosp Careggi, BMT Unit, Florence, Italy

[26] CHRU Angers, BMT Unit, Angers, France

[27] EBMT, EBMT Study Off, Paris, France

[28] Azienda Osped BMM, Hematol & Bone Marrow Transplant Unit, Reggio Di Calabria, Italy

[29] Ist Ospitalieri Cremona, Hematol & Bone Marrow Transplant Unit, Cremona, Italy

来源：

BONE MARROW TRANSPLANTATION | 2015年 / 50卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O094

引用

页码：S55 / S55

页数：1

共 50 条

[1] Impact of response to induction chemotherapy in patients with germ cell tumors (GCT) receiving salvage high-dose chemotherapy (HDCT): an EBMT Solid Tumors Working Party (STWP)-sponsored retrospective study
Necchi, A.
Miceli, R.
Bregni, M.
Berger, L. A.
Oechsle, K.
Schumacher, K.
Bourhis, J. H.
Laszlo, D.
Flechon, A.
Arpaci, F.
Secondino, S.
Raggi, D.
Dreger, P.
Krueger, W.
Ringhoffer, M.
Unal, A.
Nagler, A.
Campos
Wahlin
Donnini, I.
Badoglio, M.
Martino, M.
Pedrazzoli, P.
Lanza, F.
BONE MARROW TRANSPLANTATION, 2015, 50 : S53 - S53
[2] Impact of response to induction chemotherapy (CT) and prior paclitaxel (TXL)-based CT on the outcome of salvage high-dose chemotherapy (HDCT) for relapsed germ-cell tumors (GCT) in the modern era: An EBMT Solid Tumors Working Party study.
Necchi, Andrea
Miceli, Rosalba
Bregni, Marco
Oechsle, Karin
Kanfer, Edward
Massard, Christophe
Flechon, Aude
Laszlo, Daniele
Arpaci, Fikret
Wuchter, Patrick
Crysandt, Martina Margrit
Unal, Ali
Nagler, Arnon
Wahlin, Anders
Michieli, Mariagrazia
Pflueger, Karl-Heinz
Ringhoffer, Mark
Badoglio, Manuela
Pedrazzoli, Paolo
Lanza, Francesco
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[3] Salvage high-dose chemotherapy (HDCT) for relapsed primary mediastinal nonseminomatous germ-cell tumors (PMNSGCT).
Taza, Fadi
Abonour, Rafat
Althouse, Sandra K.
Ashkar, Ryan
Abu Zaid, Mohammad Issam
Hanna, Nasser H.
Kessler, Kenneth A.
Adra, Nabil
Einhorn, Lawrence H.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[4] Prognostic factors for high-dose chemotherapy (HDCT) as salvage treatment in germ cell tumors (GCT)
Beyer, J
Kramar, A
Mandanas, R
Linkesch, W
Greinix, A
Droz, JP
Pico, JL
Diehl, A
Bokemeyer, C
Schmoll, HJ
Nichols, CR
Einhorn, LH
Siegert, W
BONE MARROW TRANSPLANTATION, 1998, 22 : S10 - S10
[5] Analysis of paclitaxel-based high-dose chemotherapy (Tax HD-VIP) in 18 patients (pts) with relapsed germ-cell tumors (GCT)
Lorch, A.
Neubauer, A.
Schirren, R.
Hingott, S.
Hoexter, M.
Oechsle, K.
Beyer, J.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[6] High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors
Lorch, A.
Neubauer, A.
Hackenthal, M.
Dieing, A.
Hartmann, J. T.
Rick, O.
Bokemeyer, C.
Beyer, J.
ANNALS OF ONCOLOGY, 2010, 21 (04) : 820 - 825
[7] Analysis of the contemporary use of high-dose chemotherapy (HDCT) in germ cell tumors (GCT) in Europe: Early findings of an ongoing EBMT-sponsored study
Necchi, Andrea
Badoglio, Manuela
Miceli, Rosalba
Bourhis, Jean-Henri
Laszlo, Daniele
Nicolas-Virelizter, Emmanuelle
Wuchter, Patrick
Dreger, Peter
Kruger, William Hermann
Unal, Ali
Campos, Antonio
Montoro, Juan
Raggi, Daniele
Giannatempo, Patrizia
Gianni, Alessandro M.
Pedrazzoli, Paolo
Lanza, Francesco
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[8] Outcome in 41 patients with late relapse germ cell tumors (GCT) treated with high-dose chemotherapy (HDCT)
Lorch, A.
Rick, O.
Hartmann, J. T.
Metzner, B.
Glasmacher, A.
Berdel, W.
Schirren, R.
Bokemeyer, C.
Beyer, J.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[9] HIGH-DOSE CARBOPLATIN AND ETOPOSIDE FOR SALVAGE CHEMOTHERAPY OF GERM-CELL TUMORS
LAMPE, H
DEARNALEY, DP
PRICE, A
MEHTA, J
POWLES, R
NICHOLLS, J
HORWICH, A
EUROPEAN JOURNAL OF CANCER, 1995, 31A (05) : 717 - 723
[10] High-dose chemotherapy (HDCT) as second salvage treatment in patients with multiple relapsed or refractory germ cell tumors
Beyer, J.
Hackenthal, M.
Lorch, A.
Neubauer, A.
Dieing, A.
Rick, O.
Hartmann, J. T.
Bokemeyer, C.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)

← 1 2 3 4 5 →